US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Kemira Oyj (1KEMI) 銘柄情報

Kemira Oyj (1KEMI)

0.00

0.00

(0.00%)

終了 7月5日 12:30AM

Kemira Oyj (1KEMI) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

305,234 €

発行済株式数

145,440,073

配当利回り

0.76 (4.25%)

PER

14.97

1 株当たり利益 (EPS)

1.09

歳入

2.72B

純利益

165.3M

Kemira Oyj operates as a chemicals company in Finland, rest of Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in three segments: Water Solutions, Packaging & Hygiene Solutions, and Fiber Essentials. It offers clean, safe, and affordable drinking water through effici... Kemira Oyj operates as a chemicals company in Finland, rest of Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in three segments: Water Solutions, Packaging & Hygiene Solutions, and Fiber Essentials. It offers clean, safe, and affordable drinking water through efficient water processing, wastewater treatment, and reuse, supported by advanced digital technologies for customers in municipalities and water intensive industries. The company also provides functional and safe products enabled by efficient and compliant production processes and advanced digital technologies, serving customers in packaging, board, and tissue. In addition, it offers bright, clean, and strong pulp produced through efficient pulping and bleaching processes supported by advanced digital technologies for customers in pulp production. Kemira Oyj was founded in 1920 and is headquartered in Helsinki, Finland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.kemira.com

本社

Helsinki, Finland

設立

2026

Kemira Oyj is listed in the sector of the イタリア証券取引所 with ticker 1KEMI. The last closing price for Kemira Oyj was -. Over the last year, Kemira Oyj shares have traded in a share price range of 0.00 € to 0.00 €.

Kemira Oyj currently has 145,440,073 shares in issue. Kemira Oyj has a price to earnings ratio (PE ratio) of 14.97.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

1KEMI - Frequently Asked Questions (FAQ)

What is the current Kemira Oyj share price?

The current share price of Kemira Oyj is 0.00 €

How many Kemira Oyj shares are in issue?

Kemira Oyj has 145,440,073 shares in issue

What is the 1 year trading range for Kemira Oyj share price?

Kemira Oyj has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Kemira Oyj?

The price to earnings ratio of Kemira Oyj is 14.97

What is the cash to sales ratio of Kemira Oyj?

The cash to sales ratio of Kemira Oyj is 0.87

What is the registered address of Kemira Oyj?

The registered address for Kemira Oyj is Energiakatu 4, Helsinki, Uusimaa, 00101

What is the Kemira Oyj website address?

The website address for Kemira Oyj is www.kemira.com

m0n

Imagine having a product since 2009 LoL.
Cant even pay the bills and continue to have decades upon decadesof $2.2 million in deficits. LOL
No One is Fooled

m0n

How many shareholders have passed away? I m aware of one but feel there’s more.
I FU S website has ionic studies from 2009. LoL
30 YEARS IS FASTLY APPROACHING! LoL
Same o Same o, Keep the awareness on the possibilities LoL.
No One is Fooled

barnyarddog

barnyarddog 12分前

AI Overview - Avalanche Treasury Co. (ticker: AVAT) is a Nasdaq-listed operating company that provides public market investors with direct exposure to the Avalanche blockchain ecosystem.

Rather than merely stockpiling digital assets, AVAT actively allocates capital across the Avalanc

m0n

Past 6 months WIP $150 &$130k LoL
Can’t even pay the bills without door knocking for SSI $$$ in January 2026LoL
What a Joke!
No One is Fooled

TightCoil

TightCoil 22分前

Glen Bradford - Looks Like Trump Team Simply Maximizing Frannie IPO (OTCMKTS:FNMAS)
Seeking Alpha - 17 hours ago

TechBullion
Could Pepeto Be the Best Crypto Presale to Buy as
Fannie Mae Opens the Door to Crypto Mortgages?
5 hours ago

weenphan

weenphan 29分前

https://www.otcmarkets.com/stock/CVALF/profile

Kool Aid Man

Kool Aid Man 30分前

Measly $44k left in the gas tank

40 million shares left to issue x .0011

No one goes public if they intend to self finance operations. The whole point is to print and sell shares to raise money...not to reward old bag holders who were conned by Miro years ago. Why split

jondoeuk

jondoeuk 31分前

Calling this the "gold standard" doesn't answer all the underlying concerns. This isn't a refinement of the original external-control analysis either. It uses a completely different set of external comparator trials. That means the reported survival estimate depends on which external patients are se

manibiotech

manibiotech 33分前

Yes we all know that . The previous external control arm patients were “external” , and the one’s in new PSM analysis are also different ‘external’ patients with patient level propensity matching ( so even better controls) and show even better treatment benefit . So again, what is the point you are

Naught

Naught 34分前

Should we expect some notices from. PAC in the very near term then...?

weenphan

weenphan 34分前

I posted on the PCHM board for over a decade. I bought PCHM as low as .0013 and sold stock as high as $5 plus. It was a once in a lifetime percentage gainer. My aliases were LMLYP, Rosesarefree and GeneandDean, which all are references to a band Ween. I'm weenphan on this board.

newflow

newflow 34分前

Ron, Dissolved vs Extinct
No Altaba distributed immediately before dissolution, can you find any company distributing value to equity holders after its complete dissolution long-form or regular Dissolution.
Gemini's Response:
It is important to clarify a key point about Delaware

DA88

Can someone explain who this guy is and why his perspective matters? Love that he is positive, but he doesn’t look like he is anything more than a shareholder.

PickStocks

PickStocks 37分前

Yes….but we do not have anything to do with Paladin. So it means nothing which is easily verified by a simple phone call….

jondoeuk

jondoeuk 42分前

Whether this particular analysis has been submitted is something nobody outside NWBO and the MHRA knows.

jondoeuk

jondoeuk 44分前

This is not simply a refinement of the published JAMA Oncology analysis. It's a different external-control analysis built from a different pool of comparator trials. The fact they constructed a propensity-score matched analysis using individual patient data from AVAGLIO, CENTRIC, and CORE, means the

ihorchu

ihorchu 46分前

A fantastic day to remember! Since no humidity here, heat is very tolerable.

jondoeuk

jondoeuk 51分前

'While encouraging, our clinical findings must be interpreted with caution. Even though this was a randomized clinical trial (randomization software assigned patients to TLR agonist/placebo groups), the small number of patients enrolled contributed to an imbalance in patient selection between the tr

kevindenver

kevindenver 51分前

Nowhere in the interview was "Blarcamesine" mentioned. There was a snippet towards the end where autophagy is mentioned.

Maybe you hallucinated that this interview was related to blarcamesine?

A transcript of the interview can be found here:
https://podcasts.hap

TightCoil

TightCoil 59分前

Yes, next week is the week we FLY

TightCoil

TightCoil 1時間前

FNMA/FMCC
On Schwab Now
FNMA ask $7.33
FMCC ask $9.31
Load up Early
Remember:Again- Will you be quick enough to grab some of these shares once one or more current "announcements in the making," are made? Will you be quicker than the big gun buying stampede when eve

JonDoe1

JonDoe1 1時間前

He's extra angry today. Possibly hit the 4th of July drinks a little early. That poor keyboard.

kenjiroo

kenjiroo 1時間前

Happy 4th longs !!!

American Water Works

Star Combo Pharma

Kora Saude Participacoes... ON

Hanesbrands Inc Dl 01

Prompt Participacoes ON

Pegasus Tel (ID)

Capitalworks Emerging Ma...

RSE Archive (GM)

Hybrid Software

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。